Abstract
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have